ABSTRACT

Injection snoreplasty is a recently described office procedure that treats palatal flutter snoring. A sclerotherapy agent is injected into the midline soft palate submucosa in order to reduce or eliminate primary palatal snoring by inducing scarring or controlled fibrosis. There are several office procedures available for the treatment of palatal flutter snoring but injection snoreplasty has the relative advantages of being simple to perform, producing minimal comparative discomfort, and being very inexpensive. The technique described in this chapter was first introduced through a prospective, nonrandomized human-use pilot study at Walter Reed Army Medical Center (1). Intermediate-term data as well as objective data confirming palatal stiffening efficacy were also recently published (2).